Evosep
Private Company
Total funding raised: $21.5M
Overview
Evosep is a proteomics technology company developing hardware and consumables to standardize and automate workflows for liquid chromatography-mass spectrometry (LC-MS). Its core platform, centered on the Evosep Eno chromatography system and Evotip Pure disposable trap columns, is designed to dramatically increase throughput and reproducibility in protein analysis for research and clinical diagnostics. By simplifying complex proteomics processes, Evosep targets the growing need for scalable, robust tools to validate biomarkers and advance personalized medicine, positioning itself as a key enabler in the transition of proteomics from research to the clinic.
Technology Platform
Integrated liquid chromatography and consumable platform (Evosep Eno system and Evotip Pure) for standardized, high-throughput sample preparation and separation in mass spectrometry-based proteomics.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Evosep competes in the proteomics workflow sector against major life science tools companies like Thermo Fisher Scientific, Waters, and Agilent, which offer traditional HPLC/UPLC systems. Its differentiation lies in its specialized focus on standardized, high-throughput proteomics workflows using disposable tips. It also competes with other niche players and startups developing microfluidic and automated sample preparation solutions for MS.